Provided by Tiger Fintech (Singapore) Pte. Ltd.

Can Fite Biofarma

1.20
-0.0300-2.44%
Post-market: 1.200.00000.00%19:53 EDT
Volume:349.49K
Turnover:427.01K
Market Cap:15.42M
PE:-1.10
High:1.27
Open:1.27
Low:1.18
Close:1.23
Loading ...
Jun 03, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 29, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 28, 2019

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers
May 24, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 23, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 22, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 20, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 20, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 06, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 03, 2019

Public Prospectus

Registration statement for certain foreign private issuers
May 01, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 15, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 10, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 04, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 02, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 02, 2019

[Rev.]Annual Report

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 28, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 26, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 20, 2019

Correspondence

[Cover]Correspondence
Mar 12, 2019

[Amend]Public Prospectus

[Amend] Registration statement for certain foreign private issuers